1. Home
  2. AMRX vs SOC Comparison

AMRX vs SOC Comparison

Compare AMRX & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • SOC
  • Stock Information
  • Founded
  • AMRX 2002
  • SOC 2020
  • Country
  • AMRX United States
  • SOC United States
  • Employees
  • AMRX N/A
  • SOC N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • SOC
  • Sector
  • AMRX Health Care
  • SOC
  • Exchange
  • AMRX Nasdaq
  • SOC Nasdaq
  • Market Cap
  • AMRX 2.4B
  • SOC 2.2B
  • IPO Year
  • AMRX N/A
  • SOC N/A
  • Fundamental
  • Price
  • AMRX $7.36
  • SOC $20.16
  • Analyst Decision
  • AMRX Strong Buy
  • SOC Buy
  • Analyst Count
  • AMRX 5
  • SOC 4
  • Target Price
  • AMRX $10.80
  • SOC $26.25
  • AVG Volume (30 Days)
  • AMRX 2.0M
  • SOC 1.8M
  • Earning Date
  • AMRX 05-02-2025
  • SOC 05-14-2025
  • Dividend Yield
  • AMRX N/A
  • SOC N/A
  • EPS Growth
  • AMRX N/A
  • SOC N/A
  • EPS
  • AMRX N/A
  • SOC N/A
  • Revenue
  • AMRX $2,793,957,000.00
  • SOC N/A
  • Revenue This Year
  • AMRX $10.49
  • SOC N/A
  • Revenue Next Year
  • AMRX $7.00
  • SOC N/A
  • P/E Ratio
  • AMRX N/A
  • SOC N/A
  • Revenue Growth
  • AMRX 16.73
  • SOC N/A
  • 52 Week Low
  • AMRX $5.18
  • SOC $10.11
  • 52 Week High
  • AMRX $9.48
  • SOC $32.33
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 40.90
  • SOC 43.30
  • Support Level
  • AMRX $6.69
  • SOC $16.26
  • Resistance Level
  • AMRX $7.29
  • SOC $20.44
  • Average True Range (ATR)
  • AMRX 0.39
  • SOC 2.11
  • MACD
  • AMRX -0.04
  • SOC -0.09
  • Stochastic Oscillator
  • AMRX 35.71
  • SOC 39.20

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About SOC Sable Offshore Corp. Common Stock

Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California.

Share on Social Networks: